Clinton Group’s Exact Sciences EXAS Stock Holding History

Clinton Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-24,498	Closed	-$455K	–	858
2016 Q3	$455K	Buy	+24,498	New	+$432K	0.02%	700

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Clinton Group's EXAS Position: Q4 2016 in Review

Clinton Group sold out of Exact Sciences (EXAS) in Q4 2016, closing a stake of 24,498 shares — an estimated $455K sold.

Clinton Group first reported a position in EXAS in Q3 2016 and held it in 1 quarter. The position peaked at $455K in Q3 2016. 222 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

Clinton Group reported no remaining Exact Sciences position as of Q4 2016 after selling out during the quarter.
Clinton Group sold 24,498 Exact Sciences shares in Q4 2016, an estimated $455K.
Clinton Group first reported a position in Exact Sciences in Q3 2016 and held it in 1 quarter.
Clinton Group's Exact Sciences position peaked at $455K in Q3 2016.
222 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on Clinton Group's 13F filing for Q4 2016, filed 14 Feb 2017.